What Does Half-Life Mean in Peptide Research?

Half-life — written t½ — is the time it takes for the concentration of a substance in the blood to fall to half its starting value. For peptides it is the number that decides whether a molecule can become a medicine.

Why peptides start with a problem

Peptide hormones evolved to be destroyed quickly. A signal that persists is a signal that cannot be modulated, so the body maintains a dedicated apparatus for clearing them: circulating peptidases, kidney filtration, receptor-mediated uptake.

The result is that native peptide hormones have half-lives measured in minutes. GLP-1 lasts roughly two minutes before dipeptidyl peptidase-4 cleaves it. Growth hormone-releasing hormone is comparable. Native ghrelin, likewise.

A drug that disappears in two minutes is not a drug. It is an infusion at best.

The two engineering strategies

Almost every long-acting peptide drug in use today applies one or both of these.

1. Block the enzyme

If a specific protease cleaves at a specific site, change the amino acid at that site. Semaglutide substitutes the alanine at position 8 of GLP-1 — the residue DPP-4 recognises — with a non-standard amino acid the enzyme cannot process. The molecule keeps its receptor activity and loses its main route of destruction.

2. Hitch a ride on albumin

Albumin is the most abundant protein in plasma and circulates for about three weeks. Attach a fatty acid chain to a peptide and it binds reversibly to albumin, which does two things: it shields the peptide from proteases, and it makes the complex too large for the kidney to filter efficiently.

CJC-1295 takes this further with a covalent linker. Published Phase 1 work reported an estimated half-life of 5.8 to 8.1 days for a molecule whose parent hormone lasts minutes ^[1].

Half-life is not duration of effect

This is the most common error in consumer discussion, and it runs in both directions.

Effect can outlast exposure. A peptide that triggers a change in gene expression or in cell behaviour may produce consequences that persist long after the molecule itself is gone.

Exposure can outlast effect. Continuous receptor occupancy frequently causes receptor desensitisation or downregulation. The drug is still present; the response has faded.

The honest formulation: half-life describes how long the molecule is around. What it does while it is around, and what remains afterwards, are separate empirical questions.

Reading a half-life figure critically

Whenever you see a number, check that four things come with it:

• Species. Rodent clearance is much faster than human. A half-life measured in mice does not transfer.
• Route. Subcutaneous and intravenous administration give different profiles; subcutaneous absorption can be the rate-limiting step, making the apparent half-life a property of the injection site rather than the molecule.
• Assay. Some assays detect the intact peptide; others detect fragments that are no longer active. These can differ by an order of magnitude.
• Source. Was this measured in a published study, or asserted in a product listing?